cdmo.directory
← Compare landing

ACS Dobfar vs AsymBio

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryACS DobfarAsymBio
SummaryItalian CDMO with 50 years of experience offering custom development and manufacturing of active pharmaceutical ingredients, finished dosage forms, and biotech solutions including monoclonal antibodies, with FDA and AIFA approvals.AsymBio is a CDMO providing one-stop biopharmaceutical manufacturing solutions for conjugated drugs, antibodies, and recombinant proteins, with capabilities spanning early-stage research through commercial-scale production.
Services
  • API Synthesis & Manufacturing
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Process Development
  • Formulation Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Extractables & Leachables Studies
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Process Development
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
Development capabilities
  • Analytical method development
  • Formulation development
  • ICH stability testing
Data not yet provided.
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Expression: Microbial
Locations
  • Headquarters, Tribiano, Milan, Italy
Data not yet provided.
Certifications
  • FDA · Identifier: FDA
  • AIFA · Identifier: AIFA
Data not yet provided.

Find similar companies

ACS Dobfar alternatives · AsymBio alternatives

Markdown mirror: /compare/acs-dobfar/asymbio.md